Journal
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
Volume 40, Issue 6, Pages 428-437Publisher
TAYLOR & FRANCIS INC
DOI: 10.3109/00952990.2014.933840
Keywords
Addiction; biomarker; DeltaFosB; epigenetics; transcription; treatment
Categories
Ask authors/readers for more resources
The transcription factor Delta FosB is upregulated in numerous brain regions following repeated drug exposure. This induction is likely to, at least in part, be responsible for the mechanisms underlying addiction, a disorder in which the regulation of gene expression is thought to be essential. In this review, we describe and discuss the proposed role of Delta FosB as well as the implications of recent findings. The expression of Delta FosB displays variability dependent on the administered substance, showing region-specificity for different drug stimuli. This transcription factor is understood to act via interaction with Jun family proteins and the formation of activator protein-1 (AP-1) complexes. Once AP-1 complexes are formed, a multitude of molecular pathways are initiated, causing genetic, molecular and structural alterations. Many of these molecular changes identified are now directly linked to the physiological and behavioral changes observed following chronic drug exposure. In addition, Delta FosB induction is being considered as a biomarker for the evaluation of potential therapeutic interventions for addiction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available